FDA Inspection 1103385 — Pierre Fenaux
The FDA completed an inspection of Pierre Fenaux on August 23, 2019 in Paris Cedex 10. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paris Cedex 10 (France)
Additional Details
Clinical Investigator (CI)